Science ❯ Biochemistry

Protein Function

Post-Translational Modifications Mitochondrial Damage Protein-Protein Interactions Membrane Proteins Amyloid Proteins Cofactors Drug Mechanism

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

The purchase brings a first-in-class MLLT1/3 protein degrader into Amgen’s oncology research.

Human-Specific STING Inhibitors Block Oligomerization Ahead of Clinical Evaluation